BIO-key Q1 Earnings Report Analysis

Written by Emily J. Thompson, Senior Investment Analyst

Source: seekingalpha

Updated: May 18 2026

0mins

BKYI-53.47%

Explore Agentic TradingLet AI Trade for You

Source: seekingalpha

Earnings Performance: BIO-key reported a Q1 GAAP EPS of -$0.15 with revenues of $2.15 million, reflecting a 34% year-over-year increase, yet it missed expectations by $0.05 million, indicating challenges in revenue growth.
Future Outlook: The company anticipates a 65% revenue increase in Q2 2025 to approximately $2.8 million compared to $1.7 million in Q2 2025, showcasing confidence in future growth while needing to overcome current financial pressures.
Profitability Expectations: BIO-key expects to achieve profitability in H1 2026 with projected revenues of $5 million, a significant turnaround from a net loss of $1.9 million in H1 2025, indicating efforts to improve financial health.
Cash Position: The cash position for H1 2026 is expected to remain in line with the current status, and despite challenges, the company maintains an optimistic outlook for revenue growth and improved bottom line for the full year 2026.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy BKYI?" and start using high-conviction signals backed by rigorous historical data.

Analyst Views on BKYI

About BKYI

BIO-key International, Inc. is a provider of workforce and customer identity and access management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication. The Company’s IAM platform enables secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and quality accessory fingerprint scanner and FIDO-compliant hardware to provide complete solution for identity-innovating customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

BIO-key Partners with BlueAlly for Enhanced Security Solutions

6 days agoNewsfilter

Strategic Partnership Launch: BIO-key has formed a strategic partnership with BlueAlly, successfully deploying the PortalGuard platform at AOD Federal Credit Union to eliminate user experience friction and security vulnerabilities associated with traditional Multi-Factor Authentication (MFA), thereby enhancing security for financial institutions.
Enhanced Security: By implementing BIO-key's Identity-Bound Biometrics, AOD has effectively mitigated credential-based risks, ensuring that only authorized individuals can access the system, which meets the highest regulatory compliance standards and significantly reduces the operational burden on its IT team.
Optimized User Experience: The CIO of AOD stated that BIO-key's solution offers flexibility beyond Duo Security and UserLock, combining biometric authentication with various MFA options to reduce risk and support a zero-trust strategy, while streamlining operations and boosting productivity.
Significant Market Potential: BIO-key's identity and access management software secures access for over 40 million users, and as the financial sector's demand for security increases, the company's innovations in biometrics and passwordless authentication are expected to further drive its market share growth.

BIO-key International Reports 34% Revenue Growth in Q1 2026

May 18 2026Yahoo Finance

Significant Revenue Growth: BIO-key International reported a 34% increase in Q1 2026 revenues to $2.1 million, driven by new customer acquisitions and expanded deployments, laying a solid foundation for future market expansion.
Strong Gross Margin: The company maintained a gross margin of 82% in Q1 2026, consistent with 2025, highlighting the advantages of high-margin license fee revenue and sales of fully reserved inventory, which bolster profitability.
Improved Net Loss: Although the net loss for Q1 2026 was $165,036, an improvement from $736,545 in Q1 2025, ongoing privacy and regulatory challenges in the U.S. market could impact future financial performance.
Optimistic Market Outlook: BIO-key's partnership with DLT Solutions provides a streamlined procurement path for public sector customers, which is expected to enhance market penetration in defense and financial services, strengthening its long-term growth potential.

BIO-key International Q1 2026 Earnings Call Insights

May 18 2026seekingalpha

Significant Revenue Growth: BIO-key International reported a 34% year-over-year revenue increase in Q1 2026, reaching $2.1 million compared to $1.6 million in Q1 2025, indicating strong performance from new customer acquisitions and long-term deployments in defense and financial services.
Hardware Revenue Doubling: The company's hardware revenue surged over 100% to approximately $531,000, reflecting a significant increase in hardware demand as larger licensing opportunities close, thereby enhancing profit margins.
NASDAQ Return Plan: The company is actively pursuing its NASDAQ appeal process, with a hearing scheduled for June 16, and management expresses optimism about returning to NASDAQ trading by summer, which could boost investor confidence and market recognition.
Positive Future Outlook: Management anticipates profitability and positive cash flow in Q2, emphasizing that as revenue scales up, profits will significantly increase, indicating the company's growth potential and competitive positioning in the market.